159 related articles for article (PubMed ID: 38694127)
21. Suppression of GRP78 sensitizes human colorectal cancer cells to oxaliplatin by downregulation of CD24.
Xi J; Chen Y; Huang S; Cui F; Wang X
Oncol Lett; 2018 Jun; 15(6):9861-9867. PubMed ID: 29805687
[TBL] [Abstract][Full Text] [Related]
22. S100A6 mediated epithelial-mesenchymal transition affects chemosensitivity of colorectal cancer to oxaliplatin.
Zhang C; Zeng M; Xu Y; Huang B; Shi P; Zhu X; Cao Y
Gene; 2024 Jul; 914():148406. PubMed ID: 38521111
[TBL] [Abstract][Full Text] [Related]
23. Gambogic acid reverses oxaliplatin resistance in colorectal cancer by increasing intracellular platinum levels.
Wang Q; Wei J; Wang C; Zhang T; Huang D; Wei F; He F; Cai W; Yang P; Zeng S; Li W; Cao J
Oncol Lett; 2018 Aug; 16(2):2366-2372. PubMed ID: 30008940
[TBL] [Abstract][Full Text] [Related]
24. Pregnane X receptor is associated with unfavorable survival and induces chemotherapeutic resistance by transcriptional activating multidrug resistance-related protein 3 in colorectal cancer.
Dong Y; Wang Z; Xie GF; Li C; Zuo WW; Meng G; Xu CP; Li JJ
Mol Cancer; 2017 Mar; 16(1):71. PubMed ID: 28356150
[TBL] [Abstract][Full Text] [Related]
25. Overexpressed CES2 has prognostic value in CRC and knockdown CES2 reverses L-OHP-resistance in CRC cells by inhibition of the PI3K signaling pathway.
Zhang Y; Sun L; Sun Y; Chen Y; Wang X; Xu M; Chi P; Xu Z; Lu X
Exp Cell Res; 2020 Apr; 389(1):111856. PubMed ID: 31981591
[TBL] [Abstract][Full Text] [Related]
26. Nitrogen permease regulator-like 2 enhances sensitivity to oxaliplatin in colon cancer cells.
Liu MN; Liu AY; Du YJ; Pei FH; Wang XH; Chen J; Liu D; Liu BR
Mol Med Rep; 2015 Jul; 12(1):1189-96. PubMed ID: 25777765
[TBL] [Abstract][Full Text] [Related]
27. GDF15 induces chemoresistance to oxaliplatin by forming a reciprocal feedback loop with Nrf2 to maintain redox homeostasis in colorectal cancer.
Lin H; Luo Y; Gong T; Fang H; Li H; Ye G; Zhang Y; Zhong M
Cell Oncol (Dordr); 2024 Feb; ():. PubMed ID: 38386232
[TBL] [Abstract][Full Text] [Related]
28. miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression.
Zhou H; Lin C; Zhang Y; Zhang X; Zhang C; Zhang P; Xie X; Ren Z
Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28217977
[TBL] [Abstract][Full Text] [Related]
29. Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer.
Wang X; Ghareeb WM; Zhang Y; Yu Q; Lu X; Huang Y; Huang S; Sun Y; Chi P
J Cell Physiol; 2019 Aug; 234(10):18180-18191. PubMed ID: 30859572
[TBL] [Abstract][Full Text] [Related]
30. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells.
Ren T; Hou J; Liu C; Shan F; Xiong X; Qin A; Chen J; Ren W
Biomed Pharmacother; 2019 Sep; 117():109171. PubMed ID: 31261026
[TBL] [Abstract][Full Text] [Related]
31. PTBP1 knockdown overcomes the resistance to vincristine and oxaliplatin in drug-resistant colon cancer cells through regulation of glycolysis.
Cheng C; Xie Z; Li Y; Wang J; Qin C; Zhang Y
Biomed Pharmacother; 2018 Dec; 108():194-200. PubMed ID: 30219676
[TBL] [Abstract][Full Text] [Related]
32. Cyr61 mediates oxaliplatin resistance in colorectal cancer cells by regulating Bcl-xL expression.
Song Y; Kang Y; Lin Z; Zeng M; Shi P; Lin J; Lu P; Luo L; Cao Y; Zhu X
J Cancer; 2021; 12(7):1952-1959. PubMed ID: 33753993
[TBL] [Abstract][Full Text] [Related]
33. Sphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ceramide accumulation and Akt activation.
Nemoto S; Nakamura M; Osawa Y; Kono S; Itoh Y; Okano Y; Murate T; Hara A; Ueda H; Nozawa Y; Banno Y
J Biol Chem; 2009 Apr; 284(16):10422-32. PubMed ID: 19240026
[TBL] [Abstract][Full Text] [Related]
34. IRF-1 mediated long non-coding RNA PVT1-214 promotes oxaliplatin resistance of colorectal cancer via miR-128 inhibition.
Tong D; Zou E; Bai L; Ma J; Guo N; Wang H; Jiang L
J BUON; 2020; 25(5):2205-2214. PubMed ID: 33277837
[TBL] [Abstract][Full Text] [Related]
35. miR-33a-5p in small extracellular vesicles as non-invasive biomarker for oxaliplatin sensitivity in human colorectal cancer cells.
Tanaka S; Hosokawa M; Miyamoto T; Nakagawa A; Haruna M; Ueda K; Iwakawa S; Ogawara KI
Biochem Biophys Rep; 2021 Jul; 26():100996. PubMed ID: 33898768
[TBL] [Abstract][Full Text] [Related]
36. Curcumin Regulates ERCC1 Expression and Enhances Oxaliplatin Sensitivity in Resistant Colorectal Cancer Cells through Its Effects on miR-409-3p.
Han W; Yin H; Ma H; Wang Y; Kong D; Fan Z
Evid Based Complement Alternat Med; 2020; 2020():8394574. PubMed ID: 33014113
[TBL] [Abstract][Full Text] [Related]
37. miR-124 Intensified Oxaliplatin-Based Chemotherapy by Targeting CAPN2 in Colorectal Cancer.
Xie XQ; Wang MJ; Li Y; Lei LP; Wang N; Lv ZY; Chen KL; Zhou B; Ping J; Zhou ZG; Sun XF
Mol Ther Oncolytics; 2020 Jun; 17():320-331. PubMed ID: 32382656
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of CD44v6 contributes to acquired chemoresistance via the modulation of autophagy in colon cancer SW480 cells.
Lv L; Liu HG; Dong SY; Yang F; Wang QX; Guo GL; Pan YF; Zhang XH
Tumour Biol; 2016 Jul; 37(7):8811-24. PubMed ID: 26747179
[TBL] [Abstract][Full Text] [Related]
39. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
[TBL] [Abstract][Full Text] [Related]
40. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137.
Liang J; Tian XF; Yang W
World J Gastroenterol; 2020 Apr; 26(13):1474-1489. PubMed ID: 32308348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
